In migraine, activation of the immune-neurological system occurs, resulting in the release of pro-inflammatory cytokines such as tumor necrosis factor-alpha and interleukins, especially interleukin-1 beta and interleukin-6. The gene discussed is IL1B; the disease is migraine disorder.